Clinical Trial: Low-Dose Naltrexone for the Treatment of Complex Regional Pain Syndrome

Study Status: Recruiting
Recruit Status: Recruiting
Study Type: Interventional

Official Title: Low-Dose Naltrexone for the Treatment of Complex Regional Pain Syndrome

Brief Summary: The investigators are testing treatment with low-dose naltrexone (LDN) for symptom relief of complex regional pain syndrome (CRPS). Study participants will be randomly assigned to receive either LDN or placebo for a period of several weeks. During this period participants will be asked to come to several visits, which will include sensory testing, physical assessments, and questionnaires.

Detailed Summary:
Sponsor: Stanford University

Current Primary Outcome: Changes in pain severity [ Time Frame: Approximately 4 weeks after conclusion of treatment. ]

Daily pain reports on a 0-10 numerical rating scale for pain, where 0=no pain and 10=pain as bad as you can imagine


Original Primary Outcome: Same as current

Current Secondary Outcome:

Original Secondary Outcome:

Information By: Stanford University

Dates:
Date Received: July 15, 2015
Date Started: June 2015
Date Completion: June 2019
Last Updated: April 28, 2016
Last Verified: April 2016